← Leaderboards
Robert R Montgomery
Medical College Of Wisconsin
$28,575,312
Attributed
$30,613,492
Total exposure
22
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$63,252,230 · 24
By mechanism
P01$53,763,273 · 15
R01$8,895,967 · 4
M01$592,990 · 5
Top collaborators
- Thomas Calvin Abshire5 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- David Allen Wilcox$6,145,617
- Alice Rock$0
Others in their field
Top investigators on “Von Willebrand Factor”
- Jose Aron Lopez · Baylor College Of Medicine$16,844,145
- David Ginsburg · University Of Michigan At Ann Arbor$14,023,276
- Zaverio M Ruggeri · Scripps Research Institute$11,965,401
- X. Long Zheng · University Of Kansas Medical Center$10,198,380
- Renhao Li · Emory University$9,914,119
- Jing-Fei Dong · University Of Maryland Baltimore$9,840,470
Research focus
Von Willebrand FactorProgramsPlasmaMolecularHemorrhageBiologyVon Willebrand DiseasePhenotypeBaseBlood PlateletsSamplingVariantDiagnosticMutationLaboratoriesDiagnosisSymptomsCohortCodeAffectGeneticVwf GeneFundingAntibodies
Grant awards (97)
Zimmerman Program on the Biology of VWD$2,629,473
P01 · FY2023 · HL · contact PI
Project-004$379,972
P01 · FY2023 · HL · contact PI
Project 1: Molecular Impact of VWF on Clinical VWD$332,485
P01 · FY2023 · HL · contact PI
Core A: Administrative Core$325,786
P01 · FY2023 · HL · contact PI
Zimmerman Program on the Biology of VWD$2,630,440
P01 · FY2022 · HL · contact PI
Project-004$342,071
P01 · FY2022 · HL · contact PI
Project 1: Molecular Impact of VWF on Clinical VWD$299,346
P01 · FY2022 · HL · contact PI
Core A: Administrative Core$293,319
P01 · FY2022 · HL · contact PI
Zimmerman Program on the Biology of VWD$2,638,519
P01 · FY2021 · HL · contact PI
Molecular Interactions of FVIII and VWF$586,287
R01 · FY2021 · HL · contact PI
Project-004$381,842
P01 · FY2021 · HL · contact PI
Project 1: Molecular Impact of VWF on Clinical VWD$333,511
P01 · FY2021 · HL · contact PI
Core A: Administrative Core$326,811
P01 · FY2021 · HL · contact PI
Zimmerman Program on the Biology of VWD$2,661,927
P01 · FY2020 · HL · contact PI
Molecular Interactions of FVIII and VWF$586,287
R01 · FY2020 · HL · contact PI
Project-004$385,848
P01 · FY2020 · HL · contact PI
Project 1: Molecular Impact of VWF on Clinical VWD$336,265
P01 · FY2020 · HL · contact PI
Core A: Administrative Core$329,571
P01 · FY2020 · HL · contact PI
Zimmerman Program on the Biology of VWD$2,734,788
P01 · FY2019 · HL · contact PI
Molecular Interactions of FVIII and VWF$586,287
R01 · FY2019 · HL · contact PI
Project-004$456,795
P01 · FY2019 · HL · contact PI
Project 1: Molecular Impact of VWF on Clinical VWD$379,996
P01 · FY2019 · HL · contact PI
Core A: Administrative Core$366,251
P01 · FY2019 · HL · contact PI
Comparative Effectiveness in the Diagnosis of VWD$807,300
R01 · FY2018 · HL · contact PI
Molecular Interactions of FVIII and VWF$586,287
R01 · FY2018 · HL · contact PI
Comparative Effectiveness in the Diagnosis of VWD$817,579
R01 · FY2017 · HL · contact PI
Zimmerman Program for the Molecular and Clinical Biology of VWD$2,033,622
P01 · FY2016 · HL · contact PI
Comparative Effectiveness in the Diagnosis of VWD$829,339
R01 · FY2016 · HL · contact PI
Administrative and Clinical Acquisition Core$591,014
P01 · FY2016 · HL · contact PI
VWF Phenotyping and Molecular Analysis Core$451,575
P01 · FY2016 · HL · contact PI
Genetic Determinants of Quantitative Variants of von Willebrand Disease$370,809
P01 · FY2016 · HL · contact PI
Molecular Mechanisms of VWF Alteration in Vitro/Vivo$316,383
P01 · FY2016 · HL · contact PI
Molecular Impact of VWF on Clinical VWD$303,841
P01 · FY2016 · HL · contact PI
Zimmerman Program for the Molecular and Clinical Biology of VWD$2,003,117
P01 · FY2015 · HL · contact PI
Comparative Effectiveness in the Diagnosis of VWD$840,880
R01 · FY2015 · HL · contact PI
Administrative and Clinical Acquisition Core$584,913
P01 · FY2015 · HL · contact PI
VWF Phenotyping and Molecular Analysis Core$445,475
P01 · FY2015 · HL · contact PI
Critical molecular interactions of VWF and FVIII$384,655
P01 · FY2015 · HL · contact PI
Genetic Determinants of Quantitative Variants of von Willebrand Disease$364,708
P01 · FY2015 · HL · contact PI
Molecular Mechanisms of VWF Alteration in Vitro/Vivo$310,282
P01 · FY2015 · HL · contact PI
Molecular Impact of VWF on Clinical VWD$297,739
P01 · FY2015 · HL · contact PI
Zimmerman Program for the Molecular and Clinical Biology of VWD$1,992,950
P01 · FY2014 · HL · contact PI
Administrative and Clinical Acquisition Core$582,880
P01 · FY2014 · HL · contact PI
VWF Phenotyping and Molecular Analysis Core$443,439
P01 · FY2014 · HL · contact PI
Critical molecular interactions of VWF and FVIII$418,847
P01 · FY2014 · HL · contact PI
Genetic Determinants of Quantitative Variants of von Willebrand Disease$362,675
P01 · FY2014 · HL · contact PI
Molecular Mechanisms of VWF Alteration in Vitro/Vivo$308,249
P01 · FY2014 · HL · contact PI
Molecular Impact of VWF on Clinical VWD$295,707
P01 · FY2014 · HL · contact PI
Zimmerman Program for the Molecular and Clinical Biology of VWD$1,886,361
P01 · FY2013 · HL · contact PI
Comparative Effectiveness in the Diagnosis of VWD$781,263
R01 · FY2013 · HL · contact PI
Administrative and Clinical Acquisition Core$561,356
P01 · FY2013 · HL · contact PI
VWF Phenotyping and Molecular Analysis Core$431,905
P01 · FY2013 · HL · contact PI
Critical molecular interactions of VWF and FVIII$406,880
P01 · FY2013 · HL · contact PI
Genetic Determinants of Quantitative Variants of von Willebrand Disease$346,476
P01 · FY2013 · HL · contact PI
Molecular Mechanisms of VWF Alteration in Vitro/Vivo$288,905
P01 · FY2013 · HL · contact PI
Molecular Impact of VWF on Clinical VWD$257,719
P01 · FY2013 · HL · contact PI
Zimmerman Program for the Molecular and Clinical Biology of VWD$2,030,543
P01 · FY2012 · HL · contact PI
Administrative and Clinical Acquisition Core$595,217
P01 · FY2012 · HL · contact PI
Critical molecular interactions of VWF and FVIII$427,393
P01 · FY2012 · HL · contact PI
Molecular Impact of VWF on Clinical VWD$277,008
P01 · FY2012 · HL · contact PI
Critical molecular interactions of VWF and FVIII$460,645
P01 · FY2011 · HL · contact PI
Molecular and Clinical Biology of VWD$1,917,824
P01 · FY2009 · HL · contact PI
MOLECULAR IMPACT OF VWF ON CLINICAL VWD$364,766
P01 · FY2009 · HL · contact PI
VWF PHENOTYPING AND MOLECULAR ANALYSIS CORE$352,323
P01 · FY2009 · HL · contact PI
Molecular and Clinical Biology of VWD$1,956,927
P01 · FY2008 · HL · contact PI
MOLECULAR IMPACT OF VWF ON CLINICAL VWD$374,363
P01 · FY2008 · HL · contact PI
VWF PHENOTYPING AND MOLECULAR ANALYSIS CORE$359,148
P01 · FY2008 · HL · contact PI
Molecular and Clinical Biology of VWD$1,817,069
P01 · FY2007 · HL · contact PI
VWF PHENOTYPING AND MOLECULAR ANALYSIS CORE$373,513
P01 · FY2007 · HL · contact PI
MOLECULAR IMPACT OF VWF ON CLINICAL VWD$342,583
P01 · FY2007 · HL · contact PI
Structure and Function of the VWF Propeptide$342,223
R01 · FY2007 · HL · contact PI
Molecular and Clinical Biology of VWD$1,822,444
P01 · FY2006 · HL · contact PI
VWF PHENOTYPING AND MOLECULAR ANALYSIS CORE$470,246
P01 · FY2006 · HL · contact PI
Biomolecular Interactions of Factor VIII and von Willebrand Factor$380,024
P01 · FY2006 · HL · contact PI
Structure and Function of the VWF Propeptide$342,176
R01 · FY2006 · HL · contact PI
MOLECULAR IMPACT OF VWF ON CLINICAL VWD$338,793
P01 · FY2006 · HL · contact PI
PATHOPHYSIOLOGICAL MECHANISMS IN TYPE I VWD$35,390
M01 · FY2006 · RR · contact PI
PATHOPHYSIOLOGICAL MECHANISMS IN TYPE I VWD$9,009
M01 · FY2006 · RR · contact PI
Molecular and Clinical Biology of VWD$1,882,734
P01 · FY2005 · HL
VWF PHENOTYPING AND MOLECULAR ANALYSIS CORE$456,654
P01 · FY2005 · HL
Structure and Function of the VWF Propeptide$340,204
R01 · FY2005 · HL
MOLECULAR IMPACT OF VWF ON CLINICAL VWD$335,877
P01 · FY2005 · HL
PATHOPHYSIOLOGICAL MECHANISMS IN TYPE I VWD$28,175
M01 · FY2005 · RR
Structure and Function of the VWF Propeptide$344,796
R01 · FY2004 · HL
Pathophysiological Mechanisms in Type I vWD$23,533
M01 · FY2004 · RR
STRUCTURE/FUNCTION OF VWAGII$300,318
R01 · FY2002 · HL
MOLECULAR AND CELLULAR CONSEQUENCES OF VWF ALTERATION$273,227
P01 · FY2002 · HL
STRUCTURE/FUNCTION OF VWAGII$294,150
R01 · FY2001 · HL
MOLECULAR AND CELLULAR CONSEQUENCES OF VWF ALTERATION$273,227
P01 · FY2001 · HL
CORRELATION OF PLASMA LEVELS IN VWF WITH THE VWF ALLELE AND ABO BLOOD TYPE$248,088
M01 · FY2001 · RR
MOLECULAR VARIANTS CAUSING VON WILLEBRAND DISEASE$248,088
M01 · FY2001 · RR
INTEGRATIVE APPROACH TO CORONARY THROMBOSIS$113,364
R01 · FY2001 · HL
STRUCTURE/FUNCTION OF VWAGII$288,163
R01 · FY2000 · HL
MOLECULAR AND CELLULAR CONSEQUENCES OF VWF ALTERATION$273,227
P01 · FY2000 · HL
INTEGRATIVE APPROACH TO CORONARY THROMBOSIS$109,064
R01 · FY2000 · HL
MOLECULAR VARIANTS CAUSING VON WILLEBRAND DISEASE$707
M01 · FY2000 · RR
MOLECULAR VARIANTS CAUSING VON WILLEBRAND DISEASE$0
M01 · FY2000 · RR